NYSEARCA:INFU • US45685K1025
The current stock price of INFU is 8.77 USD. In the past month the price increased by 8.94%. In the past year, price increased by 9.9%.
ChartMill assigns a technical rating of 4 / 10 to INFU. When comparing the yearly performance of all stocks, INFU turns out to be only a medium performer in the overall market: it outperformed 46.85% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to INFU. INFU has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.32. The EPS increased by 220% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.92% | ||
| ROA | 5.59% | ||
| ROE | 9.96% | ||
| Debt/Equity | 0.38 |
11 analysts have analysed INFU and the average price target is 14.48 USD. This implies a price increase of 65.15% is expected in the next year compared to the current price of 8.77.
For the next year, analysts expect an EPS growth of 31.07% and a revenue growth 2.9% for INFU
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.03 | 99.028B | ||
| CI | THE CIGNA GROUP | 9.27 | 76.092B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 100.72 | 24.114B | ||
| LH | LABCORP HOLDINGS INC | 16.05 | 23.844B | ||
| DGX | QUEST DIAGNOSTICS INC | 20.16 | 23.483B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.622B | ||
| DVA | DAVITA INC | 11.82 | 10.457B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.24 | 7.237B | ||
| CHE | CHEMED CORP | 15.98 | 5.616B | ||
| RDNT | RADNET INC | 87.75 | 5.579B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
INFUSYSTEM HOLDINGS INC
3851 West Hamlin Road
Rochester Hills MICHIGAN 48309 US
CEO: Richard DiIorio
Employees: 502
Phone: 12482911210
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
The current stock price of INFU is 8.77 USD. The price decreased by -4.57% in the last trading session.
INFU does not pay a dividend.
INFU has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
INFU stock is listed on the NYSE Arca exchange.
The PE ratio for INFUSYSTEM HOLDINGS INC (INFU) is 27.41. This is based on the reported non-GAAP earnings per share of 0.32 and the current share price of 8.77 USD.
INFUSYSTEM HOLDINGS INC (INFU) has a market capitalization of 178.38M USD. This makes INFU a Micro Cap stock.